PLX
Protalix BioTherapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Protalix BioTherapeutics has 3 disclosed suppliers and 4 disclosed customers in SEC filings.
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+7.82%
vs ±12.4% implied · ×0.63
shaded = implied · ▲▼ = realized
Expected move
Inputsspot 2.59exp Nov 20ATM strike 2.5ATM straddle 0.40IV 81%
Protalix BioTherapeutics, Inc.
2.60
−0.01 · −0.57%
post 2.60 0.00%
SentenceUnder the F/F Agreement, we agreed to supply Chiesi with drug substance for pegunigalsidase alfa and, following relevant technology and technical information transfer activities, Chiesi has agreed, among other things, to provide us with commercial fill/finish services for pegunigalsidase alfa, including to support the anticipated global launch of pegunigalsidase alfa.
PLX 10-Kaccession 0001104659-26-029858
SentenceThe FIH study was conducted at New Zealand Clinical Research (NZCR) under the New Zealand Medicines and Medical Devices Safety Authority (MedSafe) and the Health and Disability Ethics Committee (HDEC) guidelines.
PLX 10-Kaccession 0001104659-26-029858
SentenceSecarna plans to apply OligoCreator ® , its proprietary AI-empowered oligonucleotide discovery and development platform, to design and profile ASO candidates against those targets.
PLX 10-Kaccession 0001104659-26-029858
SentenceWe face the risk of lower than anticipated purchases of BioManguinhos alfataliglicerase by the Brazilian MoH.
PLX 10-Kaccession 0001104659-26-029858
SentenceWe have agreed to sell drug substance to Pfizer and Chiesi for the production of Elelyso and Elfabrio, respectively.
PLX 10-Kaccession 0001104659-26-029858
SentenceFiocruz has not complied with the purchase requirements of the Brazil Agreement in the past, and we expect Fiocruz will continue to not comply and may otherwise materially breach the agreement.
PLX 10-Kaccession 0001104659-26-029858
Linked news